Timectame and Myathenea Gravis

We showed a couple of years ago that timectame had favorable impact on my teneograpis at three years. And there'v been a question before the thi matime trial was done, on how persistent any benefit of thymectime might be. So we hade the opportunity to look at patients up to five years, given the length of the recruitment period for the ti mactime trial. And so we followed them, and this was still rader blinded through five years. The benefits include disease status, as measured primarily by the c m g, but other commonly used outcome measures in myathenea gravis.